Countries Australia
Avance Clinical Briefs 45 Korean Biotechs on Global Drug Development
Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy...
October 23, 2023 | News
Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs
Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertis...
October 17, 2023 | News
Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio
First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...
October 13, 2023 | News
EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand
EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...
October 12, 2023 | News
CSL Inks Renewable Power Deal with AGL for Australian Manufacturing
The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites ...
October 12, 2023 | News
Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test
This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...
October 12, 2023 | News
Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.
In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...
October 11, 2023 | News
Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated
COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...
October 04, 2023 | News
Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...
September 29, 2023 | News
Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors
An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...
September 29, 2023 | News
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...
September 27, 2023 | News
Australia Launches National Study on Back and Neck Pain Risk Factors
The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...
September 18, 2023 | News
Asia Pacific Nations Grapple with Plummeting Fertility Rates and Environmental Crisis, Urgent Actions Needed
Societies around the world are being confronted by inexorable evidence of falling fertility rates and environmental collapse that pose major threats to hum...
September 08, 2023 | News
"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"
In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...
September 06, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
